2m 2m 2m 2m 2m 2m 2m
DENALI THERAPTCS (DNLI)
NASDAQ
$18.94+$0.26 (+1.39%)
Price as of Oct 22, 2026 7:30 PM EDT- $3.0BMarket Cap
- 17.12%1-Year Change
- BiotechnologyIndustry
DENALI THERAPTCS (DNLI)
$18.94+$0.26 (+1.39%)
Earnings Score
Valuation | DNLI | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | DNLI | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -9.36% | ||
12-Month Momentum | 27.36% | ||
3-Month Risk Adjusted Momentum | -59.87% | ||
12-Month Risk Adjusted Momentum | 50.57% |
True Yield
Valuation | DNLI | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.62% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | DNLI | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |